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Abstract. Cys-loop receptors are membrane-spanning neurotransmitter-gated ion channels
that are responsible for fast excitatory and inhibitory transmission in the peripheral and central
nervous systems. The best studied members of the Cys-loop family are nACh, 5-HT3,
GABAA and glycine receptors. All these receptors share a common structure of five subunits,
pseudo-symmetrically arranged to form a rosette with a central ion-conducting pore. Some are
cation selective (e.g. nACh and 5-HT3) and some are anion selective (e.g. GABAA and glycine).
Each receptor has an extracellular domain (ECD) that contains the ligand-binding sites,
a transmembrane domain (TMD) that allows ions to pass across the membrane, and an
intracellular domain (ICD) that plays a role in channel conductance and receptor modulation.
Cys-loop receptors are the targets for many currently used clinically relevant drugs
(e.g. benzodiazepines and anaesthetics). Understanding the molecular mechanisms of these
receptors could therefore provide the catalyst for further development in this field, as well as
promoting the development of experimental techniques for other areas of neuroscience.
In this review, we present our current understanding of Cys-loop receptor structure and
function. The ECD has been extensively studied. Research in this area has been stimulated in
recent years by the publication of high-resolution structures of nACh receptors and related
proteins, which have permitted the creation of many Cys loop receptor homology models of
this region. Here, using the 5-HT3 receptor as a typical member of the family, we describe how
homology modelling and ligand docking can provide useful but not definitive information about
ligand interactions. We briefly consider some of the many Cys-loop receptors modulators.
We discuss the current understanding of the structure of the TMD, and how this links to the
ECD to allow channel gating, and consider the roles of the ICD, whose structure is poorly
understood. We also describe some of the current methods that are beginning to reveal the
differences between different receptor states, and may ultimately show structural details of
transitions between them.
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1. Introduction
Cys-loop ligand-gated ion channels (LGICs) are membrane-spanning proteins that are activated
by neurotransmitters ; they are responsible for fast excitatory and inhibitory neurotransmission in
the central and peripheral nervous systems. Vertebrate members of this family include serotonin
(5-HT3), acetylcholine (nicotinic ACh or nACh), glycine (Gly), c-aminobutyric acid (GABAA,
GABAC) and zinc-activated (ZAC) receptors (R). There are also a range of invertebrate Cys-loop
receptors gated by the same and other neurotransmitters (e.g. EXP-1, MOD-1, pHCl, HisCl,
RDL, GluCl and SsCl), and related proteins have been identified in prokaryotes (e.g. ELIC and
GLIC). Cys-loop receptors are the major targets for many active compounds, including anaes-
thetics, muscle relaxants, insecticides and a range of drugs that treat neurological disorders such
as Alzheimer’s, anxiety, epilepsy, learning, attention deficit and drug addiction. Methods such as
high throughput screening (HTS) and fragment-based drug discovery (FBDD) use blind searches
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of large compound libraries to find drug candidates, but a rational design of more effective drugs
requires a detailed molecular knowledge of the sites at which they act. For Cys-loop receptors,
this information lags behind that of many other proteins.
Cys-loop receptors derive their name from a 13-amino-acid loop within the extracellular
domain (ECD) that is enclosed by a pair of disulphide-bonded Cys residues. Members of the
family share a common structure, consisting of five pseudo-symmetrically arranged subunits
surrounding a central ion-conducting pore (Fig. 1). Most receptors have more than one type of
subunit, and these can combine in different combinations to yield a complex array of (usually)
heteromeric receptor stoichiometries, with varying physiological and pharmacological properties.
Each receptor family is selective for either cations or anions, and their activation can be either
excitatory or inhibitory, depending on the distribution of ions at either side of the membrane,
and the membrane potential of the cell. The structure of the subunits has been studied using a
variety of biochemical techniques such as mutagenesis, photolabelling and cryo-electron micro-
scopy, and more recently by X-ray crystallography. Each subunit can be functionally separated
into three domains : The large ECD contains the ligand-binding site and is a major target for
therapeutics. The transmembrane domain (TMD) consists of four membrane-spanning a-helices
(M1–M4) that enable ions to cross the membrane and is the target for compounds such as
alcohols, anaesthetics and steroids. The intracellular domain (ICD) is primarily formed by the large
M3–M4 intracellular loop (y100–270 residues), and is responsible for receptor modulation,
sorting and trafficking, and contains portals (openings) that allow ions access in and out of
the pore and influence ion conductance. Recent studies have described homologous bacterial
proteins that do not possess a Cys-loop or an ICD, and deletion studies in the 5-HT3R and
GABACR suggest that the ICD is not essential for the expression of vertebrate receptors
(Bocquet et al. 2007; Jansen et al. 2008).
In summary, all Cys-loop receptors share homologous structures, and the basic mechanisms
by which they function are also similar. In this review, we look at all members of the family,
although concentrating largely on the 5-HT3R, to explore the relationship between structure and
function. The 5-HT3R is a typical Cys-loop receptor, and has the advantage that it functions as a
homomeric receptor, which simplifies the interpretation of experimental data. This protein has
also been used extensively in homology modelling and ligand docking (Maksay et al. 2003; Reeves
et al. 2003; Thompson et al. 2005 ; Yan & White, 2005). As this technique is becoming an
accepted route to understanding the structural details of the proteins, we use the new homology
models and docked ligands to explore the validity of these techniques to define specific mol-
ecular interactions with agonists and antagonists in the 5-HT3 ligand-binding site.
For further reading, a number of recent reviews also cover some of the topics discussed here
(Arias, 2006 ; Auerbach, 2010 ; Barnes et al. 2009 ; Chen, 2010 ; Corringer et al. 2010 ; Hogg et al.
2003 ; Lynch, 2004, 2009 ; Millar & Gotti, 2009 ; Peters et al. 2005, 2010 ; Webb & Lynch, 2007 ;
Yakel, 2010).
2. Subunit stoichiometry
The stoichiometry of the neuromuscular nAChR was the first to be determined, and revealed
that four different subunits formed a functional pentameric receptor with the stoichiometry
a2bcd (Karlin et al. 1983). Determining the stoichiometry of other receptors has proved to
be more problematic, as there are large numbers of subunits that could potentially contribute
(e.g. 19 in the GABAA receptor family), and it is becoming apparent that different arrangements
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may exist even with the same subunit types (Gotti et al. 2007 ; Millar & Gotti, 2009 ; Millar &
Harkness, 2008 ; Olsen & Sieghart, 2009). For example, neuronal a4b2 nAChR may be a2b3
or a3b2, which have differing pharmacologies (Moroni & Bermudez, 2006 ; Moroni et al.
2006). Studies indicate, however, that only a limited number of the possible stoichiometries are
Fig. 1. Important functional components of the 5-HT3 receptor, a typical member of the Cys-loop family of
LGICs. The structure shown is a 5-HT3 homology model based on a 4 A˚-resolution structure of the nAChR
(Miyazawa et al. 2003 ; PDB ID: 2BG9). The 5-HT3 receptor, like the other members, consists of five
subunits (1–5). The receptor is shown from above and from the side with two (red & blue) of the five
subunits highlighted. Specific residues of interest are highlighted in yellow. The receptor is modular in
nature and can be considered as having three main regions termed the ECD, TMD and ICD. The ECD
contains the ligand-binding site that is formed by the convergence of six peptide loops located at the
interface of two adjacent subunits (Noam et al. 2008; Thompson & Lummis, 2006). Three rings of charged
amino acids (extracellular, intermediate and cytoplasmic) are found in the pore lining a-helices of the TMD
(Gunthorpe & Lummis, 2001; Thompson & Lummis, 2003), and a hydrophobic constriction in the centre
of the channel acts as the channel gate (Panicker et al. 2002).
452 A. J. Thompson et al.
found in vivo, possibly because of cell-specific expression and/or interactions between subunit
interfaces that form during receptor assembly (e.g. neuronal GABAA receptors are pre-
dominantly a12b22c2). Receptor types may also be restricted to specific regions of the body (e.g.
GABAC receptors are largely restricted to retinal bipolar cells ; Cutting et al. 1991 ; Enz & Cutting,
1999). Some Cys-loop receptors have considerably fewer potential stoichiometries. For example,
there are only four known isoforms of the GlyR a-subunit (a1–a4) and a single b-subunit, with
the probable stoichiometry of a13b2 or a14b (Lynch, 2009 ; Webb & Lynch, 2007), and only a
single subunit has been described for vertebrate Zn2+-activated receptors (Davies et al. 2002).
Invertebrate receptors may also have multiple subunits ; several glutamate-gated and pHCl re-
ceptor subunits have been reported, although currently there are only two known histamine-
gated receptor subunits (HisCl1 and HisCl2SsCl) and single SsCl and MOD-1 receptor subunits
(Cully et al. 1996, 1994; Mounsey et al. 2007; Ranganathan et al. 2000 ; Zheng et al. 2002).
Prokaryotic receptors discovered to date also only have single subunits, but as many of these
have only recently been described, the diversity of their subunits types may grow with further
investigation (Bocquet et al. 2007; Hilf & Dutzler, 2008 ; Nury et al. 2009).
The 5-HT3R is an example of a Cys-loop receptor with relatively few subunits ; five have been
identified to date (A–E), although like many other receptors, some of these demonstrate a further
level of complexity that results from different splice-variations and differing post-translational
modifications (Bruss et al. 2000 ; Tzvetkov et al. 2007 ; Werner et al. 1994). For example, there
are long and short forms of the mouse 5-HT3A subunit that differ by six amino acids, and
there are three translational variants of the human 5-HT3B subunit (Fig. 2). Only 5-HT3A
subunits can form functional homomeric 5-HT3Rs, and appear to be obligatory in heteromeric
receptors (Holbrook et al. 2009 ; Niesler et al. 2007). Of the heteromeric receptors, only 5-HT3AB
receptors have been extensively characterized and, compared to homomeric 5-HT3A, 5-HT3AB
receptors differ in their EC50, Hill slope, desensitization kinetics, shape of current–voltage re-
lationship, and most noticeably, a much larger single-channel conductance (y16 pS in 5-HT3AB
compared to <1 pS in 5-HT3A; Davies et al. 1999; Dubin et al. 1999). However, the pharma-
cology of 5-HT3A and 5-HT3AB receptors is almost identical, suggesting that they contain a
common binding site (an A–A interface), a hypothesis supported by a recent study of mouse
5-HT3AB receptors (Brady et al. 2001; Lochner & Lummis, 2010), but conflicting with the
BABBA arrangement determined using atomic force microscopy (Barrera et al. 2005). The sub-
unit types and stoichiometry of 5-HT3Rs have been recently reviewed (Barnes et al. 2009; Jensen
et al. 2008).
3. The ECD
3.1 Structure
Recent X-ray crystal structures of the nAChR ECD have revealed molecular details of residues
that contribute to the ligand-binding domain, but such studies of whole receptors, or even ECD
pentamers are proving difficult to obtain (Dellisanti et al. 2007). Therefore, most molecular
details of Cys-loop receptors have been extrapolated from 4 A˚ resolution cryo-electron micro-
scopy images of the nAChR, or from higher-resolution images of related acetylcholine
binding proteins (AChBPs) and bacterial receptors. AChBPs are homologous to the ECD of
nACh (y25% amino-acid sequence identity) and other Cys-loop receptors (15–20% identity).
The original AChBP structure was determined at 27 A˚ resolution in 2001 (Brejc et al. 2001), and
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5-HT3A          ------------------MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLL 
5-HT3AL         ------------------MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLL 
5-HT3AT         ------------------MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLL 
5-HT3B          ------------------MLSSVMAPLWACIL--VAAGILATDTHHPQDSALYHLSKQLL 
5-HT3BR1        -------------------------------MIVYFPGILATDTHHPQDSALYHLSKQLL 
5-HT3BR2        ------------------------------------------------------------ 
5-HT3C          MLAFILSRATPRPALGPLSYREHRVALLHLTHSMSTTGRGVTFTINCSGFGQHGADPTAL 
5-HT3D          ------------------------------------------------------------- 
5-HT3E         MLAFILSRATPRPALGPLSYRERRVALLHLTHSMSTTGRGVTFTINCSGFGQHGADPTAL 
5-HT3A          TN--YRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFLQWNPE 
5-HT3AL         TN--YRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFLQWNPE 
5-HT3AT         TN--YRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFLQWNPE 
5-HT3B          QK--YHKEVRPVYNWTKATTVYLDLFVHAILDVDAENQILKTSVWYQEVWNDEFLSWNSS 
5-HT3BR1        QK--YHKEVRPVYNWTKATTVYLDLFVHAILDVDAENQILKTSVWYQEVWNDEFLSWNSS 
5-HT3BR2        ------------------------------------------------------------ 
5-HT3C          NSVFNRKPFRPVTNISVPTQVNISFAMSAILDV---------------VWDNPFISWNPE 
5-HT3D          ------------------------------------------------------------ 
5-HT3E         NSVFNRKPFRPVTNISVLTQVNISFAMSAILDVNEQLHLLSSFLWLEMVWDNPFISWNPE 
5-HT3A          DFDNITKLSIPTDSIWVPDILINEFVDVGKSPNIPYVYIRHQGEVQNYKPLQVVTACSLD 
5-HT3AL         DFDNITKLSIPTDSIWVPDILINEFVDVGKSPNIPYVYVHHRGEVQNYKPLQLVTACSLD 
5-HT3AT         DFDNITKLSIPTDSIWVPDILINEFVDVGKSPNIPYVYIRHQGEVQNYKPLQVVTACSLD 
5-HT3B          MFDEIREISLPLSAIWAPDIIINEFVDIERYPDLPYVYVNSSGTIENYKPIQVVSACSLE 
5-HT3BR1        MFDEIREISLPLSAIWAPDIIINEFVDIERYPDLPYVYVNSSGTIENYKPIQVVSACSLE 
5-HT3BR2        MFDEIREISLPLSAIWAPDIIINEFVDIERYPDLPYVYVNSSGTIENYKPIQVVSACSLE 
5-HT3C          ECEGITKMSMAAKNLWLPDIFIIELMDVDKTPKGLTAYVSNEGRIRYKKPMKVDSICNLD 
5-HT3D          ------------------------------------------------------------ 
5-HT3E         ECEGITKMSMAAKNLWLPDIFIIELMDVDKTPKGLTAYVSNEGRIRYKKPMKVDSICNLD 
5-HT3A          IYNFPFDVQNCSLTFTSWLHTIQDINISLWRLPEKVKS-DRSVFMNQGEWELLGVLPYFR 
5-HT3AL         IYNFPFDVQNCSLTFTSWLHTIQDINISLWRLPEKVKS-DRSVFMNQGEWELLGVLPYFR 
5-HT3AT         IYNFPFDVQNCSLTFTSWLHTSGHPPAAPLLCG-QPAT-AQHLPHGHGHRGLLPAPQQWR 
5-HT3B          TYAFPFDVQNCSLTFKSILHTVEDVDLAFLRSPEDIQH-DKKAFLNDSEWELLSVSSTY- 
5-HT3BR1        TYAFPFDVQNCSLTFKSILHTVEDVDLAFLRSPEDIQH-DKKAFLNDSEWELLSVSSTY- 
5-HT3BR2        TYAFPFDVQNCSLTFKSILHTVEDVDLAFLRSPEDIQH-DKKAFLNDSEWELLSVSSTY- 
5-HT3C          IFYFPFDQQNCTLTFSSFLYTVDSMLLDMEKEVWEITDASRNILQTHGEWELLGLSKAT- 
5-HT3D          -------------------------MASMSIVKATSNTISQCGWSASANWTPS-ISPSM- 
5-HT3E         IFYFPFDQQNCTLTFSSFLYTVDSMLLDMEKEVWEITDASRNILQTHGEWELLGLSKAT- 
5-HT3A          EFSMESSNYYAEMKFYVVIRRRPLFYVVSLLLPSIFLMVMDIVGFYLPPNSGERVSFKIT 
5-HT3AL         EFSMESSNYYAEMKFYVVIRRRPLFYVVSLLLPSIFLMVMDIVGFYLPPNSGERVSFKIT 
5-HT3AT         EG---LFQDYTPPGLLGLPDHRF------------------------------------- 
5-HT3B          SILQSSAGGFAQIQFNVVMRRHPLVYVVSLLIPSIFLMLVDLGSFYLPPNCRARIVFKTS 
5-HT3BR1        SILQSSAGGFAQIQFNVVMRRHPLVYVVSLLIPSIFLMLVDLGSFYLPPNCRARIVFKTS 
5-HT3BR2        SILQSSAGGFAQIQFNVVMRRHPLVYVVSLLIPSIFLMLVDLGSFYLPPNCRARIVFKTS 
5-HT3C          AKLSRGGNLYDQIVFYVAIRRRPSLYVINLLVPSGFLVAIDALSFYLPVKSGNRVPFKIT 
5-HT3D          DRAERSPSALSPTQVAIRHRCRPSPYVVNFLVPSGILIAIDALSFYLPPESGNCAPFKMT 
5-HT3E         AKLSRGGNLYDRIVFYVAIRRRPSLYVINLLVPSGFLVAIDALSFYLPVKSGNRVPFKIT 
5-HT3A          LLLGYSVFLIIVSDTLPATAIGTPLIGVYFVVCMALLVISLAETIFIVRLVH-KQDLQQP 
5-HT3AL         LLLGYSVFLIIVSDTLPATAIGTPLIGVYFVVCMALLVISLAETIFIVRLVH-KQDLQQP 
5-HT3AT         ------------------------------------------------------------ 
5-HT3B          VLVGYTVFRVNMSNQVPRSVGSTPLIGHFFTICMAFLVLSLAKSIVLVKFLHDEQRGGQE 
5-HT3BR1        VLVGYTVFRVNMSNQVPRSVGSTPLIGHFFTICMAFLVLSLAKSIVLVKFLHDEQRGGQE 
5-HT3BR2        VLVGYTVFRVNMSNQVPRSVGSTPLIGHFFTICMAFLVLSLAKSIVLVKFLHDEQRGGQE 
5-HT3C          LLLGYNVFLLMMSDLLPTS--GTPLIGVYFALCLSLMVGSLLETIFITHLLHVATTQPPP 
5-HT3D          VLLGYSVFLLMMNDLLPAT—-STSKRGVYFALCLSLMVGSLLETIFITHLLHVATTQPLP 
5-HT3E         LLLGYNVFLLMMSDLLPTS--GTPLIGVYFALCLSLMVGSLLETIFITHLLHVATTQPPP 
Loop D 
Loop A Loop E 
Loop B Loop F 
Loop C M1 
SHASLVRPHPSR
M2 
KAPPGSRAQSGEKPAPSHLLHVSLASALGCTG
M3 
Fig. 2. (Cont.)
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since this time other AChBP structures have been reported (e.g. Celie et al. 2004, 2005b ;
Hansen & Taylor, 2007 ; Hibbs et al. 2009). The similarity between AChBP and the ECD of
Cys-loop receptors was confirmed when the structures of an nACh subunit monomer and
subsequently homologous prokaryotic receptors were determined (Bocquet et al. 2009; Dellisanti
et al. 2007 ; Hilf & Dutzler, 2008 ; Nury et al. 2009). With this similarity established, we can be
more confident that studies that utilized the AChBP structure to make predictions within Cys-
loop receptors were broadly correct. A review of prokaryotic receptors can be found in Corringer
et al. (2010).
3.2 The ligand-binding site
Early biochemical and labelling studies indicated that Cys-loop receptor ligand-binding sites were
constituted by three non-contiguous regions from the ECDs of two contributing subunits. With
the advent of the AChBP crystal structure, it was confirmed that the binding site was at the
interface between two adjacent subunits (Brejc et al. 2001 ; Celie et al. 2004, 2005a, 2005b). The
two adjacent subunits are termed the principal and complementary subunits, and the binding site
is formed by three peptide loops (loops A–C) from the principal subunit, and three b-sheets
5-HT3A          VPAWLRHLVLERIAWLLCLREQSTSQRPPATSQATKTDDCSAMGNHCSHMGGPQDFEKSP 
5-HT3AL         VPAWLRHLVLERIAWLLCLREQSTSQRPPATSQATKTDDCSAMGNHCSHMGGPQDFEKSP 
5-HT3AT         ------------------------------------------------------------ 
5-HT3B          QP-------------FLCLRGDTDADRPRVEPRAQR-----AVVTESSLYG--------- 
5-HT3BR1        QP-------------FLCLRGDTDADRPRVEPRAQR-----AVVTESSLYG--------- 
5-HT3BR2        QP-------------FLCLRGDTDADRPRVEPRAQR-----AVVTESSLYG--------- 
5-HT3C          LPRWLHSLL------LHCNSPGRCC--PTAPQKENK----GPGLTPTHLPG-----VKEP 
5-HT3D          LPRWLHSLL------LHCTGQGRCC--PTAPQKGNK----GPGVTPTHLPG-----VKEP 
5-HT3E         LPRWLHSLL------LHCNSPGRCC--PTAPQKENK----GPGLTPTHLPG-----VKEP 
5-HT3A          RDRCSPPPPPREASLAVCGLLQELSSIRQFLEKRDEIREVARDWLRVGSVLDKLLFHIYL 
5-HT3AL         RDRCSPPPPPREASLAVCGLLQELSSIRQFLEKRDEIREVARDWLRVGSVLDKLLFHIYL 
5-HT3AT         ------------------------------------------------------------ 
5-HT3B          -EHLAQPGTLKEV-------WSQLQSISNYLQTQDQTDQQEAEWLVLLSRFDRLLFQSYL 
5-HT3BR1        -EHLAQPGTLKEV-------WSQLQSISNYLQTQDQTDQQEAEWLVLLSRFDRLLFQSYL 
5-HT3BR2        -EHLAQPGTLKEV-------WSQLQSISNYLQTQDQTDQQEAEWLVLLSRFDRLLFQSYL 
5-HT3C          EVSAGQMPGPAEAELTG---GSEWTRAQREHEAQKQHS--VELWLQFSHAMDAMLFRLYL 
5-HT3D          EVSAGQMPGPGEAELTG---GSEWTRAQREHEAQKQHS--VELWVQFSHAMDTLLFRLYL 
5-HT3E         EVSAGQMPGPAEAELTG---GSEWTRAQREHEAQKQHS--VELWLQFSHAMDAMLFRLYL 
5-HT3A          LAVLAYSITLVMLWSIWQYA 
5-HT3AL         LAVLAYSITLVMLWSIWQYA 
5-HT3AT         -------------------- 
5-HT3B          FMLGIYTITLCSLWALWGGV 
5-HT3BR1        FMLGIYTITLCSLWALWGGV 
5-HT3BR2        FMLGIYTITLCSLWALWGGV 
5-HT3C          LFMASSIITVICLWNT---- 
5-HT3D          LFMASSILTVIVLWNT---- 
5-HT3E         LFMASSIITVICLWNT---- 
M4 
Fig. 2. Alignment of human 5-HT3 receptor subunits. The binding loops (A–F) and transmembrane
(M1–M4) regions are highlighted by horizontal lines above the text. Conserved residues are highlighted with
a grey background. The human alternative long (5-HT3AL), truncated (5-HT3AT), Brain1 (5-HT3BR1) and
Brain2 (5-HT3BR2) forms are shown. The boxes show the additional residues found in 5-HT3AL (32 amino
acids) and 5-HT3D (12 amino acids) variants. Accession numbers for the alignment are as follows : 5-HT3A
P46098, 5-HT3B O95264 and 5-HT3C Q6V706. 5-HT3D and 5HT3E were taken from Niesler et al. (2003).
5-HT3AL and 5-HT3AT were taken from Bruss et al. (2000). 5-HT3BR1 and 5-HT3BR2 were taken from
Tzvetkov et al. (2007).
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(loops D–F) from the complementary subunit ; as this terminology was introduced before crys-
tallographic studies revealed the secondary structure, these regions are not all ‘ loops ’ (Fig. 3).
The exact location of the loop region varies subtly with different subunits of different re-
ceptors ; the locations that we have shown in Fig. 3 are therefore only approximate. Only one or a
few residues within each loop may face into the binding pocket, with residues in the remainder of
the loop probably maintaining the structure of the pocket and/or participating in the con-
formational changes that result in channel opening. Evidence from AChBP structures (discussed
later in section 7.5) suggests that binding of different ligands results in different movements of
the binding pocket ; the ECD generally contracts around agonists, but adopts a more open
structure with antagonists. It has been known for some time that antagonists and agonists may
interact with different binding pocket residues, and one ligand may interact with more or less
residues than another (e.g. a large nAChR antagonist such as a-bungarotoxin (a-BTX) interacts
with a much larger repertoire of residues than a small antagonist such as methyllycaconitine).
What is perhaps more surprising is that agonists do not need to interact with the same residues
to activate the receptor. For example, 5-HT forms a critical hydrogen bond with Glu129 in the
5-HT3R, but 5-FT, which still activates the receptor (albeit as a partial agonist), does not appear
to interact at all with this residue (Bower et al. 2008).
For the majority of Cys-loop receptors, at least two binding sites are required for channel
activation, and at muscle nAChRs, the principal subunits at both these sites are the a1 subtype ;
for some neuronal receptors, it appears that the two principal subunits differ within a single
receptor, for instance a4 and a6 (Champtiaux et al. 2003 ; Rayes et al. 2009). Questions about
cooperative binding are often finessed with the statement that the open state of the channel is
more likely to be associated with the presence of at least two bound agonists, although certain
mutant receptors have Hill slopes near unity, allowing for the possibility of opening with just a
single bound agonist. In some mutant receptors that are highly agonist-sensitive, there is also
constitutive activation in the total absence of agonist, as though the open state is rather more
stable than normal (e.g. Bhattacharya et al. 2004).
Cys-loop receptor-binding sites all contain a number of aromatic residues (Table 1). For many
of the Cys-loop receptors, a cation–p interaction has been described between the natural ligand
and one of these aromatic residues. This type of interaction has been observed in a variety of
proteins using high-resolution structural data, but for Cys-loop receptors cation–p interactions
have only been identified using unnatural amino acid mutagenesis (Dougherty, 2008). For this
technique, a series of electron-withdrawing or electron-donating groups are substituted onto
the side chains of aromatic residues, subtly altering the energy of the cation–p interaction. If the
EC50 varies monotonically with the calculated strength of the interaction, this is evidence for the
presence of a cation–p interaction. In all Cys-loop receptors examined to date, when a cation–p
interaction is found, the ligand interacts with only one aromatic side chain in the binding pocket ;
in some other proteins, the efficient stabilization of this bond relies upon interactions with
several aromatic rings, and the optimal orientation of the cationic centre is normal to the planes
passing through the centroids of these rings (Scha¨rer et al. 2005).
Different aromatic side chains (Trp, Phe or Tyr) make a cation–p interaction in different Cys-
loop receptors. Each of these is located in one of the three loops on the principal subunit
(Table 1) ; as yet, no cation–p interactions have been found in the complementary subunit. In the
5-HT3R, the contributing residue is a loop B Trp (Beene et al. 2002, 2004), while in the MOD-1
receptor (also activated by 5-HT) it is a Trp in loop C (W226; Mu et al. 2003). Therefore, even in
receptors activated by the same ligand, the residue involved in the cation–p interaction can differ.
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Fig. 3. AChBP, an analogous protein to the ECD of Cys-loop receptors. AChBP contains five subunits, but
for clarity only two of these are shown. The binding loops and b-sheets are shown, the positions of which
are taken from Brejc et al. (2001). The same binding loops and b-sheets are labelled in the linear amino-acid
sequence below.
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Similarly in the GABAC receptor, GABA has a cation–p interaction with a loop B Tyr residue,
but in the GABAA receptor, GABA has a cation–p interaction at a Tyr on loop A. Several
exogenous or synthetic agonists can also make cation–p interactions (e.g. epibatidine ; Cashin
et al. 2005) but it is not essential ; for example, nicotine can make a cation–p interaction at
the neuronal a4b2 nAChR, but does not make a cation–p interaction at the muscle nAChR
(Beene et al. 2002 ; Xiu et al. 2009). These data provide an explanation for the low potency
of nicotine at muscle nAChRs (and an understanding of why smoking does not cause severe
muscle contractions), and also demonstrates the importance of understanding the molecular
interactions when designing receptor-specific drugs. These data also highlight the problem that
even with good structural information, docking a ligand into a protein may not always be accu-
rate, and experimental data are essential to allow the correct solution to be selected from possible
options.
3.2.1 Ligand binding ; in silico predictions from the 5-HT3R
In silico predictions of ligand binding require either a high-resolution structure or a homology
model, and the template used for the latter will determine its accuracy. To show how differing
starting templates can introduce conformational variability, Fig. 4 overlays two 5-HT3 homology
models that were created using similar AChBP structures containing the same bound ligand
(HEPES; PDB ID’s 1I9B and 1UX2). The overlay shows that the backbones closely mirror each
other, but there are considerable differences in the orientations of side chains. Other starting
templates that contain different bound ligands produce further variation, and if we use these for
in silico docking, the positions of the side chains can have a significant impact on the final
orientation of the ligand. Nevertheless, homology models have been produced for many re-
ceptors, and a range of ligands docked into their binding sites (e.g. Abdel-Halim et al. 2008;
Cromer et al. 2002 ; Le Novere et al. 2002 ; Maksay et al. 2003 ; Reeves et al. 2003 ; Schapira et al.
2002 ; Trudell & Bertaccini, 2004 ; Yan & White, 2005). The ability of 5-HT3Rs to form homo-
meric receptors means that they are a relatively simple system for molecular modelling, and they
have the considerable advantage that the experimental determination of the effects of amino acid
substitutions on the properties of the receptor is straightforward. In the following section, this
receptor is used as a model system to illustrate some of the pros and cons of in silico techniques.
Table 1. Aromatic residues in the binding sites of different Cys-loop receptors. Residues that contribute to
cation-p interactions are shown in bold. 1,3Beene et al. (2002), 2Xiu et al. (2009), 4Mu et al. (2003),
5Padgett et al. (2007), 6Lummis et al. (2005a), 7Pless et al. (2008). See Dougherty (2008) for further
information. Note that loop D is in the complementary face, and residues from this face have not been found to
form cation–p interactions to date
Receptor Ligand Loop A Loop B Loop C Loop D
nACh (a1bcd)1 ACh Y93 W149 Y190 Y198 W55
nACh (a4b2)2 ACh, Nicotine Y98 W154 Y195 Y202 W55
5-HT3
3 5-HT E129 W183 F226 Y234 W90
MOD-14 5-HT C120 Y180 Y221 W226 F83
GABAA
5 GABA Y97 Y157 F200 Y205 F65
GABAC
6 GABA F138 Y198 Y241 Y247 Y102
Gly7 Gly F99 F159 Y202 F207 F63
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In silico docking of ligands can be performed using a variety of software tools. One of the most
widely used and well regarded is GOLD (The Cambridge Crystallographic Data Centre,
Cambridge UK), which places a ligand into the protein and then improves the fit by iteratively
moving the ligand into the most energetically favourable orientation (Olsen et al. 2004a). To
explore its accuracy, we determined whether GOLD could adequately locate binding sites and
correctly position ligands in them by removing ligands from their original protein structures
and re-docking them. Figure 5 shows the 10 predicted ligand orientations for nicotine and
carbamylcholine in their original AChBP crystal structures, and in two other randomly selected
structures. In each instance, the software correctly located the ligand within the receptor, although
there are some subtle differences in their precise orientations.
Granisetron is a selective, competitive antagonist of 5-HT3Rs. Nuclear magnetic resonance
(NMR) and crystallography studies of granisetron show that the azabicyclic of granisetron adopts
a boat–chair configuration, and the carbonyl linker is relatively immobile (i.e. rigid), with a
dihedral angle of 180x (Fludzinski et al. 1987 ; Roe & Kuntz, 1995 ; Schmidt & Peroutka, 1989 ;
Vernakar et al. 2010). Using this structure, we docked granisetron into a range of 5-HT3R
homology models, the templates of which were the 18 currently available AChBP, nACh and
prokaryotic receptor structures (Tables 2 and 3). We have used a flexible ligand (non-constrained
bond angles) and a rigid ligand (constrained bond angles), and the tables show the additional
variability that is introduced by altering the flexibility of the ligand. A comparison of the results
shows that granisetron is located in broadly similar locations in the binding pockets, although
the predicted orientations differ (Fig. 6). Flexible (Table 2) and rigid (Table 3) ligand docking
Fig. 4. An overlay of two 5-HT3 receptor homology models that were based on HEPES bound AChBP
structures (PDB ID: 1I9B white and 1UX2 orange). Some residues that have been shown to be important
for granisetron (a selective 5-HT3 antagonist) binding are highlighted and emphasize that some regions e.g.
close to W195, have large differences in the orientation of their side chains. The relative positions of the
models were compiled by Swiss-PdbViewer ‘magic fit ’ using loop B as a reference point.
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generated eight and five categories of potential ligand orientations, respectively. Rigid docking
increased the incidence of granisetron being placed outside the binding site (described as others) ;
docking errors may be responsible, although some locations may represent local energy minima
within the binding and unbinding routes, as previously suggested (Joshi et al. 2006 ; Maksay et al.
2003 ; Thompson et al. 2006a ; Zhang et al. 2006).
(A) 
(B) 
(C) 
Carbamylcholine Structure (1UV6) Nicotine Structure (1UW6) 
Docked Nicotine Docked Carbamylcholine 
Nicotine Structure (1UW6) Carbamylcholine Structure (1UV6) 
Docked Carbamylcholine Docked Nicotine 
Epibatidine Structure (2BYQ) Cobratoxin Structure (1YI5) 
enitociNdekcoDenitociNdekcoD
Fig. 5. A test for the accuracy of computational ligand docking. (A) Nicotine and carbamylcholine
re-docked into their respective AChBP structures. (B) Nicotine docked into the carbamylcholine structure
and vice versa. (C) Nicotine docked into two other AChBP structures. In each panel, the original ligand
molecule is shown in grey and 10 docking solutions are shown in white ; the ligands are clearly positioned on
top of one another within the binding site.
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An alternative method for orientating a ligand uses a protein in which a structurally similar
ligand with a common pharmacophore has been co-crystallized (Fig. 7). To predict interacting
amino acids, the new ligand can be pasted into the model. This method can result in steric clashes
between the ligand and receptor, but these can be minimized with the software. It must
be stressed, however, that all these in silico methods only estimate the possible orientations of
amino-acid side chains and docked ligands. They do nevertheless provide testable hypotheses
that can be validated by experimentation.
Table 2. Flexible ligand docking of granisetron into the 5-HT3 receptor-binding site produces docked clusters
that can be categorized into one of eight groups (A1–E). Docking solutions that place granisetron outside the
binding site are described as others. The data were created using the boat-chair configuration of granisetron
docked into a series of 5-HT3 homology models that were generated from the 18 currently available PDB
templates that show homology to Cys-loop receptors. The protein sequence of the murine 5-HT3 receptor
(accession number : Q6J1J7) was co-aligned with each of the template sequences using FUGUE, which takes
into account secondary structures (Shi et al. 2001). Using Modeller 6v2, five homology models were generated
from each PDB template (Sali & Blundell, 1993), and the best model selected using Ramachandran plot
analysis. The protonated form of granisetron was constructed in Chem3D Ultra 7.0 (CambridgeSoft,
Cambridge, UK) based on the crystal structure of a related indazole carboxamide (Cambridge Structural
Database ; reference code FIZXUH) and docked with GOLD v3.0 (The Cambridge Crystallographic Data
Centre, Cambridge, UK), into a binding site that was defined as being within 20 A˚ of the a-carbon of
W183. To dock ligands, 10 genetic algorithm runs were carried out for each homology model, with a
population size of 50 and the maximum number of generations set to 27 000. For each homology model, the
10 docking solutions were categorized according to the ligand orientation, and the number of solutions in each
category are shown (see Fig. 6 legend for descriptions)
Starting Template for
the 5-HT3R homology model
Number of ligand orientations in each
5-HT3R homology model
Protein Ligand type PDB A1 A2 B1 B2 C1 C2 D E Other
Aplysia AChBP – 2BYN 3 7
Aplysia AChBP HEPES 2BR7 7 3
Limnaea AChBP HEPES 1I9B 9 1
Limnaea AChBP HEPES 1UX2 1 6 2 1
Aplysia AChBP Epibatidine 2BYQ 3 4 1 1 1
Limnaea AChBP Carbomylcholine 1UV6 1 1 8
Limnaea AChBP Nicotine 1UW6 10
Aplysia AChBP Methyllcaconitine 2BYR 1 7 2
Aplysia AChBP Lobeline 2BYS 5 4 1
Bulinus truncatus
AChBP
CAPS 2BJO 10
Torpedo marmorata
nAChR
– 2BG9 3 1 1 5
Limnaea AChBP a-Cobratoxin 1YI5 4 5 1
Aplysia AChBP a-Cobratoxin 2BYP 3 7
Aplysia AChBP a-Conotoxin 2C9T 2 8
Erwinia LGIC – 2VL0 2 3 5
Gleobacter LGIC – 3EAM 10
Aplysia AChBP Cocaine 2PGZ 10
Aplysia AChBP Tropisetron 2WNC 1 2 1 1 4 1
Total number of orientations in each category 11 46 18 26 4 11 8 35 21
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3.2.2 Ligand binding ; experimental evidence for the 5-HT3R in silico predictions
The two methods (flexible and rigid docking) produced in total eight distinct categories (or
clusters) of ligand orientations (see Fig. 6), with, for example, 26 and 38 poses respectively in the
orientation B2. This places granisetron with the azabicyclic rings between W183 and Y234, and
the indazole ring towards loop E. Orientation A2 is the total most common (46 and 24 poses,
respectively) and has more interactions with residues that have been identified as important in
the 5-HT3R binding site (Joshi et al. 2006; Thompson et al. 2005). The orientation that is best
supported by the experimental evidence, however, is A1, where the orientation of granisetron is
reversed so that the indazole ring is located between W183 and Y234 with the azabicyclic ring
orientated towards the transmembrane region, between residues E129 and W90. Double-mutant
cycle analysis shows that the azabicyclic ring of granisetron is close to W90 and the indazole ring
is orientated away from the membrane (Yan & White, 2005), and this orientation is also sup-
ported by experimental evidence as described by both Joshi et al. (2006) and Thompson et al.
(2005). In both orientations A1 and A2, there is an interaction with W183, a residue that is
important for both agonist and antagonist binding (Beene et al. 2002 ; Spier & Lummis, 2000),
and with Y234, which also contributes to the binding site ; substitutions of Y234 to Ala or
Ser severely compromise granisetron binding, although Y234F mutants have similar binding
affinities to wild-type receptors (Spier & Lummis, 2000 ; Suryanarayanan et al. 2005). An Ala
mutation at the adjacent S233 residue also abolishes binding, which may be due to its altering the
Table 3. Rigid ligand docking of granisetron into the 5-HT3 receptor binding site produces docked clusters
which can be categorized into one of five groups. Methods used can be found in the legend of Table 2
Starting template for the 5-HT3R
homology model
Number of ligand orientations in each
5-HT3R homology model
Protein Ligand Type PDB A1 A2 B2 C1 C2 Other
Aplysia AChBP – 2BYN 10
Aplysia AChBP HEPES 2BR7 5 2 3
Limnaea AChBP HEPES 1I9B 5 2 3
Limnaea AChBP HEPES 1UX2 4 2 4
Aplysia AChBP Epibatidine 2BYQ 5 5
Limnaea AChBP Carbomylcholine 1UV6 8 2
Limnaea AChBP Nicotine 1UW6 3 1 6
Aplysia AChBP Methyllcaconitine 2BYR 7 3
Aplysia AChBP Lobeline 2BYS 1 1 8
B. truncatus
AChBP
CAPS 2BJO 3 7
T. marmorata
nAChR
– 2BG9 1 9
Limnaea AChBP a-Cobratoxin 1YI5 1 2 1 6
Aplysia AChBP a-Cobratoxin 2BYP 4 6
Aplysia AChBP a-Conotoxin 2C9 T 6 4
Erwinia LGIC – 2VL0 10
Gleobacter LGIC – 3EAM 10
Aplysia AChBP Cocaine 2PGZ 10
Aplysia AChBP Tropisetron 2WNC 5 5
Total number of orientation in each category 20 24 38 25 12 61
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location of the adjacent Y234 residue (Suryanarayanan et al. 2005). Mutation of both E129 and
W90 strongly affect granisetron binding regardless of the amino acid used, showing that they are
both essential ; E129 hydrogen bonds with 5-HT, and may similarly interact with granisetron
(Price et al. 2008 ; Spier & Lummis, 2000 ; Sullivan et al. 2006 ; Yan et al. 1999), and W90 may
(A1) (B1) (C1) (D)
(A2) (B2) (C2) (E)
Fig. 6. Examples of the eight main categories of docked poses found in the 320 homology models gen-
erated for this study. Categories were largely based on the proximity of granisetron atoms to W183, and the
orientation of the azabicyclic and indazole rings. The number of docked poses that fell into each of these
categories can be seen in Tables 2 and 3. In brief, the descriptions of these clusters are as follows :
(A1) Indazole ring close to W183 and the azabicyclic ring orientated towards the membrane. (A2) Same as
A1, but with the azabicyclic and indazole rings reversed. (B1) Indazole ring close to W183 and the azabi-
cyclic ring orientated towards Y143 in loop E. (B2) Same as B1, but with the azabicyclic and indazole rings
reversed. (C1) Carbonyl linker close to W183 and the azabicyclic ring orientated away from the membrane.
(C2) Same as (C1), but with the indazole ring orientated away from the membrane. (D) Either the azabi-
cyclic or indazole rings close to W183 and the opposite end of the ligand orientated towards loop C.
(E) Granisetron lies horizontally across the back of loop C. (Other) A number of unique positions located
throughout the ECD.
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stabilize the structure of region by a T-type interaction with Tyr234 (Gallivan & Dougherty,
1999).
Residues that have an impact on granisetron binding are shown in Fig. 8. These include
a number of residues centred around W195 and D204 in loop F. Whether the residues in
Cocaine Tropisetron 
Fig. 7. AChBP crystal structures showing the orientations of cocaine (PDB ID: 2PGZ at 176 A˚) and
tropisetron (2WNC at 22 A˚). The orientations are most similar to category E described in Fig. 6.
Fig. 8. Binding site substitutions that cause significant changes in the binding affinity of granisetron at the
5-HT3 receptor. Residues have been superimposed upon a homology model of the 5-HT3 receptor that was
generated using 1I9B. The data were taken from Beene et al. (2004), Boess et al. (1997), Joshi et al. (2006),
Price et al. (2008), Schreiter et al. (2003), Spier & Lummis (2000), Thompson et al. (2005, 2006b, 2008),
Venkataraman et al. (2002a, b), Yan et al. (1999), Yan & White (2005) and Sullivan et al. (2006).
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loop F are directly involved in ligand binding is difficult to determine from the homology
models as this region is poorly resolved in the crystal structures, and some residues may
interact with adjacent b-sheets rather than with the ligand itself (Spier & Lummis, 2000 ;
Thompson et al. 2006b). Loop E residues G148 and V150 have been shown to abolish ligand
binding when mutated to Ala and there are also effects at residues L178, F180, Q188, D189, I190
and N191 in loop B (Joshi et al. 2006 ; Thompson et al. 2008; Venkataraman et al. 2002b).
As many of these are at some distance from the binding site, and some are on opposite sides of
b-sheets, it is unlikely that they directly interact with the ligand; their effects may be due to intra-
molecular interactions that are critical for the structure of the binding site (Thompson et al.
2006b, 2008). Some of these residues have also been implicated in the binding/unbinding
pathway of the ligand, while others may contribute to the subunit interface, or be involved in
the transduction of binding energy into channel opening (Joshi et al. 2006; Thompson et al.
2006a).
3.2.3 Ligand binding : summary
Our docking results show a wide range of ligand orientations, highlighting the potential problem
of developing theories based solely on in silico predictions. We can, however, use this information
to design experiments to probe the accuracy of the predictions. For the 5-HT3R, experimental
data best support the predicted orientations of granisetron and 5-HT shown in Fig. 9, which are
not the most common docking solutions, but are in general agreement with structure–activity
relationships (Bower et al. 2008 ; Maksay et al. 2003 ; Reeves et al. 2003 ; Schmidt & Peroutka,
1989). It must also be considered that it may be possible for ligands to adopt multiple orienta-
tions. For example, molecular dynamic studies examining GABA binding to the GABACR show
that GABA appears to ‘flip ’ from one orientation to another during the simulation, although
there is currently only experimental data to support one of the orientations (Melis et al. 2008), and
in silico predictions in the 5-HT3R have concluded that there are two possible orientations for
both mCPBG and granisetron (Joshi et al. 2006; Schulte et al. 2006).
Comprehensive reports can be found elsewhere on the binding sites of 5-HT3 (Schulte
et al. 2006; Thompson & Lummis, 2006), nACh (Romanelli et al. 2007), Gly (Lynch, 2004) and
GABA receptors (Abdel-Halim et al. 2008 ; Huang et al. 2006; Korpi et al. 2002; Sedelnikova et al.
2005).
3.3 Allosteric modulation
Cys-loop receptors are allosteric proteins, but they themselves are also subject to allosteric
modulation by a wide range of organic and inorganic substances (Changeux et al. 1984). Some of
these substances occur endogenously and may reinforce or attenuate the natural response under
physiological conditions, but, given the central importance of Cys-loop receptors in the nervous
system and neurological disorders, it is not surprising that some synthetic receptor modulators
are widely used potent and effective drugs, such as the benzodiazepines, which act at GABAA
receptors. We will not attempt to describe the effects of all of these modulators, but will briefly
describe some examples to give an indication of the diversity of compounds and the range of
studies being undertaken to understand their mechanisms of action. Further information can be
obtained from the following reviews for GABAA (Huang et al. 2006 ; Olsen et al. 2004b), Gly
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(A) 
(B)
Fig. 9. Preferred orientations for 5-HT and granisetron docked into a homology model of the 5-HT3
receptor binding site. Both orientations provide the best fit for the experimental data. The ligands can
potentially interact with W183, are influenced by a range of aromatic residues that are orientated with their
p-rings normal to the ligand, and have critical hydrogen bonds interactions with E129. See text for more
details.
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(Hawthorne & Lynch, 2006 ; Lynch, 2004, 2009), nACh (Faghih et al. 2008; Arias & Bouzat,
2006) and 5-HT3 receptors (Reeves & Lummis, 2002).
3.3.1 Ions as modulators
Receptors in the Cys-loop family can be significantly affected by physiologically relevant ions
such as calcium, magnesium and zinc. The effects of these ions vary according to the receptor
type and subunit composition. For example, in the a7 nAChR, these cations potentiate re-
sponses, while 5-HT3R responses are typically reduced (Brown et al. 1998; Hu & Lovinger, 2005 ;
Hubbard & Lummis, 2000 ; Niemeyer & Lummis, 2001 ; Thompson & Lummis, 2008a). Ion-
binding sites in many Cys-loop receptors have been identified in the channel (Bertrand et al.
1993 ; Eddins et al. 2002a, 2002b; Gill et al. 1995 ; Hu & Lovinger, 2005 ; Livesey et al. 2008 ;
Niemeyer & Lummis, 2001 ; Noam et al. 2008; Quirk et al. 2004 ; Thompson & Lummis, 2008a ;
Van Hooft & Wadman, 2003), but there are also binding sites in other regions of these proteins.
A specific binding site for calcium, for example, has been identified in the ECD of the a7 nACh
(Galzi et al. 1996), and insertion of this region into the 5-HT3R results in an enhancement of
the 5-HT-induced response. This region coincides with residues that have been shown to bind
Ca2+ in AChBP (Brejc et al. 2001). Zinc-binding sites have been located at subunit interfaces in
nAChR and GlyR (Hsiao et al. 2006; Nevin et al. 2003), while in GABAA receptors, zinc binds to
both the ECD and the pore (Dunne et al. 2002; Fisher & Macdonald, 1998 ; Fisher, 2002 ;
Horenstein & Akabas, 1998 ; Hosie et al. 2003). Binding of these ions is likely to have important
physiological consequences although these are not yet fully understood. In the GABAA receptor,
for example, sensitivity to zinc changes with the onset of epilepsy (Kapur & Macdonald, 1997),
an effect that has been genetically linked to a mutation within the M2 region of the GABAA c2
subunit (Baulac et al. 2001).
3.3.2 Benzodiazepines
Benzodiazepines are an important class of therapeutic compounds that modulate GABAA
receptors by binding at the a-c subunit interface (Olsen & Sieghart, 2009). Differences in the
pharmacological profiles of different a- and c-subunit subtypes have enabled the identification
of amino-acid residues that are involved in benzodiazepine binding. For example, a1-His102
directly interacts with flunitrazepam and diazepam (Berezhnoy et al. 2004; McKernan et al. 1998 ;
Tan et al. 2007), while a1-Tyr160, a1-Tyr210 (Amin et al. 1997) and c2-Phe77 (Buhr et al. 1997a)
form part of the aromatic-binding site for benzodiazepines. Residues a1-Thr206, a1-Glu209,
a1-Tyr162, a1-Thr207, c2-Tyr58, c2-Ala79, c2-Met130 and c2-Thr142 contribute to benzo-
diazepine selectivity and efficacy (Buhr & Sigel, 1997 ; Buhr et al. 1997a, 1997b ; Kucken et al.
2000 ; Mihic et al. 1994; Sigel & Buhr, 1997 ; Teissere & Czajkowski, 2001).
The mechanisms that communicate conformational changes between the GABA- and
benzodiazepine-binding sites are less well understood. Mutations in loop F of the c2 subunit
do not change the binding affinity of benzodiazepines or the agonist response, but decrease
potentiation, indicating that this region may be involved in telegraphing the modulatory behav-
iour to other areas of the receptor (Hanson & Czajkowski, 2008 ; Padgett & Lummis, 2008).
Other regions of the protein are also probably involved, including the b10 sheet of the ECD (see
Fig. 3), and residues in M1, M2 and the M2–M3 loop (Boileau & Czajkowski, 1999; Jones-Davis
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et al. 2005). Further reading on benzodiazepines can be found in Olsen & Sieghart (2009),
Rudolph et al. (2001) and Sigel (2002).
3.3.3 Alcohols and anaesthetics
A wide range of alcohols and anaesthetics modulate Cys-loop receptor function, and their
behaviours are mostly mediated via interactions with the TMD (Arias & Bhumireddy, 2005 ;
Hawthorne & Lynch, 2006 ; Huang et al. 2006; Sessoms-Sikes et al. 2003). Effects of these
compounds vary according to the receptor type, subunit composition, and the nature and con-
centration of compound being used. For example, long n-alkanols and anaesthetics are inhibitory
at nAChRs, but ethanol is potentiating at low concentrations (Zuo et al. 2002), while 5-HT3Rs are
potentiated and inhibited depending upon the alcohol or anaesthetic (e.g. Machu & Harris, 1994 ;
Suzuki et al. 2002 ; Zhang et al. 1997). Other examples include a4b2 nAChRs, which are sensitive
to the anaesthetics isoflurane and propofol, and abcd nACh and a7 nAChRs which are not
(Flood et al. 1997; Violet et al. 1997). There are many other examples, and there are excellent re-
views on this subject by Arias & Bhumireddy (2005), Urban et al. (2006) and Yamakura et al. (2001).
3.3.4 Ivermectin – a commercially important modulator of invertebrate GluCl receptors
Ivermectin, a macrocyclic lactone produced by bacteria, is the world’s largest-selling veterinary
drug, and has also largely eradicated ‘ river blindness ’ resulting from nematode infections in sub-
Saharan Africa. Ivermectin, its avermectin analogues and the milbemycins are probably allosteric
potentiators of invertebrate GluCl channels at submicromolar concentrations (Vassilatis et al.
1997). These heteromultimeric channels, found in several invertebrate phyla, are homologous to
vertebrate GlyR (and slightly less so to GABAA receptors).
We know little about the binding site for ivermectin, but because the GluCl channels resemble
other Cys-loop receptors, it is certain that the GluClb subunit carries the principal-binding site.
The GluClb Tyr182 residue aligns with the loop B cation–p residues : Trp of the nAChR, Trp of
the 5-HT3R and (probably most similar) Phe of the GlyR (see Table 1). Substitutions to several
other residues at this position abolish the responses to both glutamate and ivermectin. However,
the GluClb-Y182F mutation decreases the maximal glutamate response by y6-fold, without
changing the ivermectin response (Li et al. 2002). This is evidence that the binding sites for
glutamate and IVM do not overlap. Twenty other mutations were studied in the b-subunit ECD;
none preserved glutamate sensitivity while abolishing ivermectin sensitivity (Li et al. 2002).
Therefore, we cannot say where ivermectin binds to GluCl channels.
GlyR are also activated by ivermectin, but are y1000-fold less sensitive (Shan et al. 2001),
suggesting that ivermectin may act differently on GlyR. Nevertheless, several GlyR-binding site
mutations abolish glycine but not ivermectin sensitivity, supporting the idea that the agonist and
ivermectin sites do not overlap (Shan et al. 2001). Also supporting the idea that ivermectin binds
at a non-agonist site, voltage-clamp fluorometry established that the 19k residue near the top of
M2 changes its environment when the channel is opened by all agonists but not when opened by
ivermectin (Pless et al. 2007).
A mystery associated with ivermectin is its very low reversibility, which vitiates concentration-
response experiments. Ivermectin effects take >8 h to wash out and this lower limit could
actually be governed by a synthesis of new receptors (Slimko et al. 2002). The most appropriate
experiments show that GluCl channels are half-activated by ivermectin during a 1 nM puff lasting
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several seconds (Slimko & Lester, 2003). In unpublished experiments (HAL lab), hypersensitive
nAChR mutants with comparably low EC50 values show washout time constants of several
minutes ; therefore, simple high affinity does not explain the long washout times for ivermectin at
GluCl channels. An unnatural Pro substitute in the M2–M3 linker of 5-HT3Rs produces an
apparently irreversible activation (Lummis et al. 2005b) with an EC50 of 20 nM, and may rep-
resent a good analogy to the action of ivermectin. Further comments on ivermectin can be found
in sections 3.3.5 and 7.5.
3.3.5 a7 nACh receptor allosteric modulators
Among the nAChRs, the a7 nAChR has received recent attention as a target for allosteric
activators (Bertrand et al. 2008 ; Hogg & Bertrand, 2007). Potent positive allosteric modulators
include NS-1738, 4-naphthalene-1-yl-3a,4,5,9b-tetrahydro-3-H-cyclopenta[c]quinoline-8-sulfonic
acid amide (TQS), PNU-120596, N-(4-chlorophenyl)-a-[[(4-chloro-phenyl)amino] methylene]-
3-methyl-5-isoxazoleacet-amide (‘compound 6’ ; Ng et al. 2007), LY-2087101(Broad et al.
2006) and galanthamine (Lopes et al. 2007) ; these act at concentrationsf10 mM. TQS and PNU-
120596, but not NS1738, have the property that they either reactivate desensitized receptors
and/or significantly retard desensitization, properties that are also shared by ivermectin at GlyR
(Gronlien et al. 2007). However, according to results from a7/5-HT3 chimeras, NS-1738 and
PNU-12059 bind at different sites. The ECD of the a7 nAChR is required for NS-1738 action,
and the ECD in combination with the M2–M3 linker of the a7 nAChR are required for agonist-
independent activity in the presence of NS-1738 (Bertrand et al. 2008). In contrast, the entire
TMD of the a7 nAChR is required for allosteric modulation by PNU-12059 (Bertrand et al.
2008).
4. The TMD
4.1 Structure
A range of experimental techniques show that the TMD is composed of four membrane span-
ning a-helices (M1–M4) from each subunit ; each receptor therefore has 20 such a-helices within
the membrane (Fig. 10). The a-helical nature of these regions, which was originally inferred from
hydropathy plots (Noda et al. 1982), was verified in the nAChR by photolabelling (Blanton &
Cohen, 1994), two-dimensional 1H-NMR spectroscopy (Lugovskoy et al. 1998), Fourier trans-
form infrared (FTIR) spectroscopy (Baenziger & Methot, 1995 ; Corbin et al. 1998; Go¨rne-
Tschelnokow et al. 1994 ; Methot et al. 1994) and mutagenesis (e.g. Tamamizu et al. 2000). The
best available structural information comes from 4 A˚ resolution cryo-electron microscopy ima-
ges of the nAChR (Miyazawa et al. 2003) ; higher-resolution structures from related prokaryotic
receptors have been solved, but it is not yet clear how representative these are of vertebrate Cys-
loop receptors (Bocquet et al. 2009 ; Hilf & Dutzler, 2008; Nury et al. 2009). The 4 A˚ nAChR
images show that a-helices from each subunit are arranged symmetrically, forming an inner ring
of M2 helices that line the central pore, and an outer ring composed of M1, M3 and M4 that
shields the inner ring from the lipid environment (De Planque et al. 2004 ; Miyazawa et al. 2003).
On the extracellular side, the transmembrane helices are spread apart, but gather together as they
cross the membrane towards the intracellular side (Goren et al. 2004; Miyazawa et al. 2003 ;
Panicker et al. 2002). Overlaying electron densities of subunits in the resting state reveals that M1,
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Fig. 10. Comparisons of TMDs from open and closed receptors. Top panel : structures of nAChR (closed; Miyazawa et al. 2003; PDB ID: 2BG9), ELIC (closed; Hilf &
Dutzler, 2008; PDB ID: 2VL0) and GLIC (open; Bocquet et al. 2007; PDB ID: 3EAM) are shown. Two (red and blue) of the five subunits are highlighted. M2 lines the
central pore, and residues that face this water accessible surface are shown in Fig. 11. Lower panels : pore diameter as calculated by HOLE, with a 15 A˚ cut-off to find the
ends of the pores (Smart et al. 1993). Each tick on the vertical axis is 25 A˚. The nAChR pore appears longer, because the structure also contains part of the ICD.
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M2 and M3 have precise positioning within the structure while the location of M4 is more
relaxed, particularly at its C-terminus. A review of pore structures can be found in Absalom et al.
(2009).
4.2 M1 and the M1–M2 loop
M1 forms part of the outer ring that is in contact with the lipid environment and may also
contact M2. Mutations in M1 have been shown to produce receptors that have altered desensi-
tization, changes in EC50 or are non-functional (Akabas & Karlin, 1995 ; Bianchi et al. 2001; Dang
et al. 2000; Engblom et al. 2002 ; England et al. 1999 ; Greenfield et al. 2002; Lobitz et al. 2001 ;
Lobo et al. 2004 ; Spitzmaul et al. 2004; Zhang & Karlin, 1997). M1 may therefore be a structural
element involved in transmitting movement of the ligand-bound ECD into M2, possibly through
direct interactions with the M2 helix following activation (Unwin et al. 2002). Indeed, some of the
roles of specific residues that contribute to this activity are beginning to emerge. For example,
the highly conserved proline residue in the centre of M1 has been shown to be critical due to its
lack of ability to act as a hydrogen bond donor (Dang et al. 2000), and may permit M2 to
transiently alter its position upon channel activation. Recent experiments introducing ionizable
side chains into M1 revealed the current response is reduced 25–50% by protonation at any of
five a-helically spaced M1 side-chains, suggesting M1 is not completely shielded from the
channel axis by M2. The data also show that the side chains closest to the axis in the open state
are also those closest in the cryo-electron microscopy studies, revealing that M1 moves little, or
may not move at all, between the open and closed states (Cymes & Grosman, 2008 ; Miyazawa
et al. 2003).
There is evidence that the region that links M1 with the ECD is an important functional
element involved in the gating process. Mutations at the extracellular end of the 5-HT3R (R222,
Hu et al. 2003), GlyR (R218, Castaldo et al. 2004), GABAAR (K215, Kash et al. 2004) and nAChR
(several residues, Zhang & Karlin, 1997) have been shown to effect receptor gating. The other
end of M1 may form part of the intracellular mass that lies at the cytoplasmic face of the pore.
Evidence from SCAM has indicated that the intracellular end of M1 and the M1–M2 linker lie
along the path of the permeating ions, and these regions contain residues responsible for anion/
cation selectivity (Filippova et al. 2004; also see section 4.4). Coordination of cadmium ions
in 5-HT3R Cys mutants and the use of negatively and positively charged thiol reactive MTS
reagents have demonstrated that residues in the M1–M2 loop are accessible (Panicker et al. 2002,
2004).
4.3 M2 lines the channel pore and acts as the channel gate
A great number of experiments over many years have shown that the residues in M2 line the
channel pore and M2 is an a-helix. In particular, substituting cysteine, histidine, lysine or arginine
residues into M2 has revealed water-accessible pore lining residues that have a periodicity con-
sistent with an a-helical conformation (Akabas et al. 1994 ; Cymes et al. 2005 ; Reeves et al. 2001 ;
Xu & Akabas, 1996 ; Zhang & Karlin, 1998). Structural data from cryo-electron microscopy
indicate that M2 is y40 A˚ long and extends beyond the embrace of the lipid environment
(Bachy et al. 1993 ; Miyazawa et al. 2003). These data also show that within the limits of the
membrane the M2 helices tilt radially towards the centre of the pore until they reach residues
6k–9k, a region that is considered to be the channel gate (Fig. 10). This is consistent with earlier
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studies that showed the binding site for the open-channel blocker QX-222 was located at the
region between 6k and 10k of the nAChR, and suggested that the open channel tapered to its
narrowest point just below 6k (Charnet et al. 1990; Leonard et al. 1988).
The centre of the pore coincides with a conserved collar of hydrophobic side chains ; in the
nAChR a1 subunit this includes Leu251, Val255 and Leu258 (Figs 1, 2, 10 and 11). Five
symmetrically placed M2 helices from each of the five subunits create a hydrophobic region that
is 3 A˚ at its narrowest and less than 35 A˚ over a distance of approximately 8 A˚ in the closed
state, and has been referred to as a hydrophobic girdle (Miyazawa et al. 2003). Ion permeabilities
suggest that the diameter of the open channel is between 74 A˚ and 84 A˚ for cation channels and
between 52 A˚ and 62 A˚ for anion channels (Brown et al. 1998 ; Cohen et al. 1992 ; Fatima-Shad
& Barry, 1993 ; Rundstrom et al. 1994 ; Wang & Imoto, 1992). Originally, the channel gate was
predicted to be close to the cytoplasmic end of M2 (Wilson & Karlin, 1998 ; Wilson et al. 2000).
This conclusion was supported by data from applying thiol reactive compounds in the closed or
open state of the receptor, but the results were limited as channels may spontaneously open,
modifying reaction rates can vary in the presence and absence of agonist and some of the
modifying reagents may be small enough to pass the closed gate (Bali & Akabas, 2007 ; Tikhonov
Fig. 11. M2 channel lining residues in different Cys-loop receptors. Pore-lining residues are shown next to
the M2 a-helix (taken from the nAChR structure ; PDB ID: 1oed). To allow for comparisons between M2
residues of different Cys-loop receptors, a prime (‘ ) notation is used : residues are assigned numbers ac-
cording to their position relative to a charged M2 residue that is conserved in Cys-loop receptors. Residues
that are accessible to modification are highlighted : 1Kaneez & White (2004), 2Reeves et al. (2001), 3Panicker
et al. (2002), 4Akabas et al. (1994), 5Xu & Akabas (1996), 6Shan et al. (2002), 7Lynch et al. (2001) and 8Lobo
et al. (2004). Accession numbers for the sequence alignment are : Mouse 5-HT3A, Q6J1J7 ; Electric Ray ACh
a1, P02710; Human GABAA, a1 P14867; Human Gly a1, P23414.
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et al. 2004; Wilson & Karlin, 2001). It is now widely accepted that the gate is located in the
centre of the channel. This constricted region shares structural similarities to the gate of other
membrane-permeable channels which are also occluded by a narrow hydrophobic region (Chang
et al. 1998), and represents the only obstruction within the channel that provides an energetic
barrier to ion permeation (Beckstein et al. 2001; Hummer et al. 2001).
4.4 M2 and ion selectivity
The residues that line the ion-accessible inner face of the channel are predominantly non-polar
except for rings of charged amino acids (Figs 1 and 11) (Akabas et al. 1992, 1994 ; Panicker et al.
2002 ; Reeves et al. 2001 ; Xu & Akabas, 1993; Xu et al. 1995 ; Zhang & Karlin, 1998). Initially,
Konno et al. (1991) reported that the three rings of charged amino acids (referred to as extra-
cellular, intermediate and cytoplasmic rings) in the nAChR M2 region were responsible for ion
selectivity, with the intermediate ring exerting the strongest influence (Fig. 11). The mechanisms
of charge selectivity were later evaluated by substituting M2 residues of the a7 nAChR with the
corresponding residues from Gly a1 (Galzi et al. 1992). As the number of mutations was
gradually reduced, the smallest number of residues required to reverse ion selectivity was found
to be valine to threonine (V251T or V9kT), neutralization of a glutamate (E237A or E-1kA) and
the insertion of a proline (P236 or P-2k) in the M1–M2 loop. Homologous changes also alter ion
selectivity in the 5-HT3 (Gunthorpe & Lummis, 2001 ; Thompson & Lummis, 2003), MOD-1
(Menard et al. 2005), GABA r (Carland et al. 2004 ; Wotring et al. 2003), GABAA (Jensen et al.
2002, 2005a) and Gly a1 receptors (Keramidas et al. 2000). The contribution of each of the three
mutations was studied in more detail in the a7 nAChR, and showed that the residue at thex1k
position is the most critical (Corringer et al. 1999a). At this position in cationic receptors gluta-
mate predominates, while the x1k residue in anionic receptors is uncharged (Keramidas et al.
2002 ; Wotring et al. 2003). In the a7 nAChR V9k was found not to be directly involved in charge
selectivity, and the effect of the Pro insertion was the result of localized structural modifications
at the intracellular end of M2 (Corringer et al. 1999a). Indeed, in the a7 nAChR, functional
anionic channels could be generated by inserting a Pro at any of the positions 234, 236 or 237,
although was dependent on being accompanied by the E237A and V251T mutations. The
structural importance of the Pro was further illustrated by changes in functional properties of the
mutant receptors, including differences in activation, desensitization, EC50, Hill co-efficient and
spontaneous channel openings (Corringer et al. 1999a ; Wotring et al. 2003). At the invertebrate
GluCl receptor, charge selectivity remains unaltered in similar Pro mutants and a structural role
was also concluded (Sunesen et al. 2006). Further complications were presented in a study by
Wotring & Weiss (2008), who also showed that the introduction of Glu residues within an eight
amino-acid stretch (x2k to 5k) of GABA r1 produces varied permeability ratios depending upon
the location of the substitution. However, in native receptors the character of thex1k residue is
conserved across the Cys-loop family, indicating that this position is critical. Consequently, the
ring of charge at the x1k position is now universally regarded as an essential component of
charge selectivity within the Cys-loop family, with other residues in the region playing some roles
in some receptors.
Mutations in the 5-HT3R close to the extracellular ring of charge have also been implicated in
charge selectivity (Thompson & Lummis, 2003). When the 19k residue is changed from a serine
to an arginine and combined with the x1k Glu to Ala mutation, the receptor is predominantly
anion selective. Importantly, unlike the triple mutants described above, these 5-HT3R mutants
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do not display concomitant changes in the biophysical properties of the channel, suggesting that
these data more accurately reflect the residues directly involved in ion selectivity. Neutralization
of R19k in the GlyR, however, does not alter ion selectivity when expressed in conjuncture with
A1kE and P2kD mutations, although it does modify conductance and rectification (Keramidas
et al. 2002; Moorhouse et al. 2002). These data indicate that there are structural differences
between the cation- and anion-selective receptors (also see section 4.5).
As functional receptors can be formed from different combinations of subunits (which have
different amino acids lining their pores), there can be large differences in the permeation of
certain ions. One of these is Ca2+, and nAChRs have a wide range of Ca2+ permeabilities (Arias,
2006 ; Cens et al. 1997 ; Gerzanich et al. 1998; Livesey et al. 2008; Noam et al. 2008 ; Tapia et al.
2007 ; Vernino et al. 1992) determined primarily by the residues located at the intermediate (x1k)
and extracellular (20k) rings (Bertrand et al. 1993 ; Galzi et al. 1992 ; Hu & Lovinger, 2005 ; Livesey
et al. 2008). For example, reduced Ca2+ conductance in (a4)2(b2)3 nAChRs compared to
(a4)3(b2)2 nAChRs is a consequence of only b2, but not a4 subunits having acidic residues
at their x1k positions (Tapia et al. 2007). Such data can be extrapolated to other receptors :
5-HT3ABR have lower Ca
2+ permeability than 5-HT3AR, which may be the consequence
of 20k residue being Asp and Asn in A and B subunits, respectively. Consistent with this, a
D20kA substitution reduces Ca2+ permeability, as does the replacement of the adjacent R19k
with Ser (Livesey et al. 2008 ; Thompson & Lummis, 2003). Recent studies suggest that the ICD
may also play a role in Ca2+ permeability as substitutions of charged residues in this region can
have a major effect on Ca2+ permeability (Livesey et al. 2008 ; Thompson & Lummis, 2003).
In both nAChR and 5-HT3Rs, Ca
2+ binding sites have also been reported in the ECD (see
section 3.3.1).
Comprehensive reviews on ion selectivity in the Cys-loop family of receptors can be found in
Jensen et al. (2005b), Keramidas et al. (2004), Peters et al. (2010) and Sine et al. (2010).
4.5 The M2–M3 loop
The M2–M3 loop forms part of the interface that links the ECD with the TMD, and it has a
critical role in transmitting the energy of binding into channel opening (discussed further in
section 6). Studies have shown that mutations in this region disrupt activation in nACh, 5-HT3,
GABA and Gly receptors (Campos-Caro et al. 1996 ; Deane & Lummis, 2001 ; Grosman et al.
2000a, 2000b ; Kusama et al. 1994 ; Lewis et al. 1998 ; Lynch et al. 1997; O’Shea & Harrison, 2000 ;
Rajendra et al. 1995 ; Rovira et al. 1998, 1999 ; Saul et al. 1999 ; Sigel et al. 1999). The structure of
this loop has been examined by a range of techniques, including NMR and electron microscopy,
and the data suggest that there are differences between cation- and anion-selective receptors. In
the nAChR, the M2 helix extends two rings above the membrane (i.e. up to the 23k residue),
while in the GlyR, the helix terminates at the 15k residue (Ma et al. 2005). The loop moves during
receptor activation ; in the Gly a1 receptor, SCAM studies reveal that all the residues within the
M2–M3 region are accessible to modification, and surface accessibility increases when the re-
ceptor is activated (Bera et al. 2002 ; Lynch et al. 2001). Specific residues in this loop play par-
ticular roles, for example, in the 5-HT3R a cis–trans isomerization of the Pro at the apex of this
loop (Pro308, P8k) can trigger channel opening (Lummis et al. 2005b). While the same mechan-
ism seems not to activate the nAChR, the equivalent proline functionally couples to flanking Val
residues extending from the b1–b2 and Cys-loops, and together these regions form a critical part
of the transduction pathway (Lee et al. 2008). A conserved proline within the Cys-loop has also
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been identified as a candidate for channel activation (Limapichat et al. 2010). This topic is also
discussed in section 6.
4.6 M3 and M4 helices
Structural data show that M3 and M4 are a-helical and shield M2 from the lipid bilayer, although
there are water-accessible clefts that lie between the TMD a-helices (Miyazawa et al. 2003 ;
Fig. 10). SCAM studies on the M3 segment of GABAA receptors show that in the absence of
GABA, only those residues towards the extracellular side of the membrane are accessible.
Activation allows modifying reagents to approach residues located closer to the centre of the M3
a-helix, as water-permeable clefts between adjacent a-helices widen as a consequence of con-
formational changes in M2 (Miyazawa et al. 2003 ; Wang et al. 1999; Williams & Akabas, 1999).
The outer face of the M3 helix is in close contact with the membrane and is inaccessible to these
modifying agents (Blanton & Cohen, 1992, 1994 ; Blanton et al. 1998). Recent nAChR experi-
ments introduced ionizable side chains into M3 to reveal relative distance from the channel’s
axis, similar to the experiments performed in M1 and M2 (Cymes et al. 2005). The extent of block
was<40% for only five side chains, limiting the precision of the data, but was not inconsistent
with the a-helical pattern and orientation of the closed state found in structural studies. M3, like
M1, apparently rotates little between the closed and open states.
Given the location and apparent roles of M3 and M4, it is surprising that mutations can
have significant effects on receptor function, but such mutations cause changes in both
the whole-cell current (Cruz-Martin et al. 2001 ; Guzman et al. 2003 ; Lasalde et al. 1996 ; Williams
& Akabas, 1999 ; Wu et al. 2010) and single-channel kinetics of nAChRs and 5-HT3Rs (Bouzat
et al. 2000, 2002 ; Corradi et al. 2009; De Rosa et al. 2002 ; Lee et al. 1994; Navedo et al. 2004 ;
Ortiz-Miranda et al. 1997; Tamamizu et al. 1999, 2000 ; Wang et al. 1999). The effect of these
mutations can be additive both in terms of the contribution from each subunit (Bouzat et al.
1998 ; De Rosa et al. 2002) and within the same a-helix (Lasalde et al. 1996), although this
observation is not supported by all studies (Cruz-Martin et al. 2001). M4 may also detect the lipid
environment and influence the functional properties of the receptor (daCosta & Baenziger,
2009).
These regions also influence receptor expression : the number and characteristics of
C-terminal residues in M4 are critical for the expression of 5-HT3R on the cell surface (Butler
et al. 2009) and the expression of non-assembling receptors that contain only the ECD and
M1–M3 helices can be rescued by co-expression with M4 (Haeger et al. 2010 ; Villmann et al.
2009). Thus, the M3 and M4 regions are an integral part of the receptor, and have a function that
extends beyond simply shielding M2 from the membrane.
5. The ICD
5.1 Structure
The structure of the ICD is unresolved apart from a single a-helix that is located in the
M3–M4 loop of each subunits. Electron microscopy-derived images at 9 A˚ resolution show that
the ICD adopts a ‘hanging-basket ’-type structure with openings or ‘portals ’ that are the likely
site of ion entry and exit to/from the channel (Hales et al. 2006; Unwin, 1993). One side of
each portal is contributed by the a-helix described above. This amphipathic a-helix was
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originally identified by sequence analysis many years ago and was considered to line the pore
(Finer-Moore & Stroud, 1984 ; Miyazawa et al. 1999). More recent studies have shown that it
contributes significantly to the channel conductance in both nAChRs and 5-HT3Rs (Hales et al.
2006 ; Peters et al. 2005). Interestingly, homologous receptors in bacteria do not have an extended
loop region between M3 and M4, which has led to experiments where this region was deleted in
5-HT3Rs and GABACRs, demonstrating that these receptors maintained most of the charac-
teristics of the parent receptor (Bocquet et al. 2007; Hilf & Dutzler, 2008 ; Jansen et al. 2008).
Thus, these regions are not essential for function or expression.
5.2 Channel conductance
Studies that demonstrated a role of the M3–M4 loop in channel conductance were originally
performed in the 5-HT3R, and more recently extended to nAChRs and GlyRs (Carland et al.
2009 ; Deeb et al. 2007; Hales et al. 2006; Kelley et al. 2003 ; Livesey et al. 2008; Peters et al. 2004).
In the 5-HT3R, A-subunits can form functional homomeric channels with a conductance<1 pS,
but when combined with B-subunits receptors display a much larger conductance (9–17 pS;
Brown et al. 1998; Davies et al. 1999 ; Derkach et al. 1989 ; Hussy et al. 1994). By replacing parts of
the A-subunit sequence with homologous regions from the B-subunit, Kelley et al. (2003)
identified three amino acids that govern the differences between the low conductance of the
homomeric receptor and the higher conductance of the heteromeric receptor, and which align
with a polar stripe of residues identified by Finer-Moore & Stroud (1984). Electrophysiological
data support the suggestion that the charged groups line portals within the sides of the ICD, and
influence the ion flux between the cytoplasm and the inner vestibule at the base of the pore
(Miyazawa et al. 1999 ; Unwin, 2000). As the widest region of the portals resembles the diameter
of a hydrated permeant ion, they provide an explanation for the homomeric 5-HT3 channel
having a much smaller unitary conductance than most nAChRs, despite their similar ionic per-
meabilities and very similar M2 sequences (Brown et al. 1998 ; Lambert et al. 1989; Malone et al.
1991 ; Mochizuki et al. 2000 ; Yakel et al. 1990; Yang, 1990). Additional studies have shown that
the conductance of the channel can be dynamically altered by sulphydryl modifying reagents
(Deeb et al. 2007) and the permeability of divalent cations is also altered by mutations in this
region (Livesey et al. 2008). A peptide that mimics this region at GABAARs similarly modulates
conductance at inside-out patches (Everitt et al. 2009). Charged residues at this location have also
been proposed to interact with phosphate groups on intracellular proteins, regulating both
channel conductance and ion selectivity (Livesey et al. 2008; Noam et al. 2008).
5.3 Intracellular modulation
Interactions of proteins and ions with the M3–M4 loop of Cys-loop receptors can modulate
receptor activity, assembly, targeting and trafficking (e.g. Akk & Steinbach, 2000 ; Bouzat et al.
1994 ; Boyd et al. 2002; Melzer et al. 2010; Yu & Hall, 1994). Some interactions are highly specific
to different subunits of different receptors, such as gephyrin that specifically targets GlyR to
postsynaptic synapses, while others are more general ; phosphorylation of the M3–M4 loop, for
example, is linked to changes in channel behaviour in nACh, 5-HT3, GABAA and Gly receptors
(Filippova et al. 2000 ; Hubbard et al. 2000 ; Lankiewicz et al. 2000 ; McDonald & Moss, 1994 ;
McDonald & Moss, 1997 ; Moss et al. 1992, 1996 ; Nishizaki & Ikeuchi, 1995 ; Nishizaki &
Sumikawa, 1998 ; Ruiz-Gomez et al. 1991; Sedelnikova & Weiss, 2002; Vaello et al. 1994;
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Van Hooft & Vijverberg, 1995 ; Wecker et al. 2001). A comprehensive series of reviews by
Connolly (2008), Gaimarri et al. (2007), Kneussel & Loebrich (2007), Millar (2008), Millar &
Harkness (2008) and Sarto-Jackson & Sieghart (2008) cover the assembly and trafficking of
nACh, 5-HT3, GABAA and Gly receptors.
A variety of kinases including casine kinase II, tyrosine kinase, protein kinase A (PKA) and
protein kinase C (PKC) phosphorylate different residues with differing effects. For example,
PKA phosphorylates Ser409 in the 5-HT3R causing an increase in the rate of desensitization
(Coultrap and Machu, 2002 ; Hubbard et al. 2000 ; Lankiewicz et al. 2000; Sun et al. 2003 ; Yakel
et al. 1990), while PKC actions on this receptor regulate the probability of certain conductance
states (Coultrap & Machu, 2002; Van Hooft & Vijverberg, 1995) and rapidly increase surface
expression (Emerit et al. 2002 ; Grailhe et al. 2004 ; Ilegems et al. 2004 ; Sun et al. 2003). Other
processes of post-translational modulation such as protein glycosylation and palmitoylation have
also been described, but the exact roles of these processes in the regulation of receptor assembly,
targeting and trafficking are not yet fully determined (e.g. Boyd et al. 2002 ; Drisdel et al. 2004 ;
Green et al. 1995).
6. Molecular basis of Cys-loop receptor activation
Binding of an agonist to its receptor causes movements of the ECD that are transduced to the
M2 helices and lead to the opening of the pore (e.g. Grosman et al. 2000b ; Lee et al. 2009; Unwin
et al. 2002). In the heteromeric nAChR, this movement is initiated within the a-subunits, which
undergo rotations, although several recent studies also describe movements that precede rotation
(Horenstein et al. 2001 ; Lape et al. 2008; Pless & Lynch, 2009 ; Unwin et al. 2002). The structural
integrity of the ECD is important as weakening backbone hydrogen bonds in the b7, b9 and b10
sheets abolish receptor function, while photochemically cleaving the backbone between loops A
and E has similar effects on GABA activation, but not on activation by pentobarbital (Gleitsman
et al. 2009 ; Hanek et al. 2010). The movement of the ECD, mediated by the M2–M3 linker at the
extracellular side of the TMD, destabilizes the hydrophobic ‘girdle ’ in the channel, which moves
away from the centre of the pore into space that resides between the inner and outer rings,
opening the channel (Law et al. 2000; Miyazawa et al. 2003). It is often claimed that Miyazawa et al.
(2003) found a ‘ rotation ’ in the M2 regions, but only rotations in the ECD were identified, along
with two alternative structures of the M2 helices : straight in the closed state and kinked in the
open state. The cytoplasmic ends of M2 remain relatively static during these events (Panicker et al.
2002, 2004). In support of this hypothesis, mutations of the gate residues affect ion permeation,
cause increased sensitivity to channel opening, slow desensitization of macroscopic currents,
increase closing events and/or increase channel open times (Chang & Weiss, 1998 ; Filatov &
White, 1995 ; Labarca et al. 1995). A collective movement of all the M2 helices is likely, as they
maintain their five-fold symmetry in both the closed and open states (Unwin, 1995), and the gate
residue aL251 effects pore opening independent of the nAChR subunit type mutated (Filatov &
White, 1995 ; Labarca et al. 1995). Gating of Cys-loop receptors can occur in the absence of
bound ligand, but at very low frequency (e.g. Jackson, 1984, 1986 ; Hu & Peoples, 2008). The
binding of ligand increases the probability of opening and maximizes as the quantity of bound
ligands rises to at least two (Beato et al. 2004; Corradi et al. 2009). As the channel opening rate can
be quicker than the dissociation rate of the ligand, several openings can occur during a single
ligand occupancy.
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Electron microscopy studies (Miyazawa et al. 2003; Unwin et al. 2002) have indicated that
the b1–b2 and b8–b9 loops and the b10 strand in the ECD are closely associated with
residues in the M2–M3 linker, providing a direct link between the ECD and TMD (Lee et al.
2008 ; Unwin, 1995 ; Unwin et al. 2002). Comparing the structures of the ELIC (apparent closed
conformation) and GLIC (apparent open conformation) prokaryotic receptors also shows dis-
tinct differences in this region (Bocquet et al. 2009 ; Hilf & Dutzler, 2008). In support of
the structural data, experiments show that coupling of binding to gating in a chimaeric
AChBP (ECD)/5-HT3 (ICD) receptor could only be achieved when these three amino-acid
loops from the ECD of the 5-HT3R were substituted into the corresponding regions of
AChBP. This indicates that compatibility between the two regions is necessary (Bouzat et al.
2004), although subsequent studies which could not repeat these functional data led these
authors to conclude that AChBP is in the desensitized form (Grutter et al. 2005b). Specific
residues in the loops at the ECD/TMD interface have been identified as playing roles in the
transduction process ; in particular, a salt-bridge between the ECD and TMD regions has
been identified in nACh (Lee & Sine, 2005) and GABAC (Price et al. 2007; Wang et al. 2007)
receptors. However, there is no such salt bridge between the equivalent residues in GABAAR
(Kash et al. 2003, 2004), 5-HT3 (Price et al. 2007) or GlyR (Schofield et al. 2003), although it
is clear that charged residues are important. A good explanation for these results is that there
is a global electrostatic attraction between the two regions (Dougherty, 2008 ; Xiu et al. 2005).
A series of recent reviews have summarized current knowledge of the changes that induce
channel opening (Bartos et al. 2009 ; Cederholm et al. 2009 ; Chang et al. 2009 ; Gay & Yakel,
2007).
7. Time-resolved structural information
It has long been a goal of biophysicists to understand the conformational changes in an ion
channel at sufficient time resolution (a) to link each structure to a functionally defined state, and
possibly (b) to visualize the transition states as well. This goal remains elusive for two reasons.
(1) Some Cys-loop receptors desensitize within a few ms after opening, and therefore, structural
measurements must have sufficient temporal resolution to distinguish between active and de-
sensitized states. (2) We do not yet understand the kinetic bases of equilibrium side chain
parameters such as polarity, polarizability, volume and (in the case of Pro), backbone cis–trans
isomerization, or how such properties govern the kinetics of changes in the secondary and
tertiary structures of proteins. Therefore, results from site-directed mutagenesis alone cannot
usually be interpreted in kinetic terms.
7.1 Time-resolved cryo-electron microscopy
Conceptually, the clearest approach is Unwin’s pioneering experiment that obtained cryo-elec-
tron microscopy data at 9 A˚ resolution from Torpedo nAChR-rich membranes, both in the closed
state, and y5 ms after ACh was sprayed onto the membrane (Unwin, 1995). Unwin identified
rotations in the ECD and two alternative structures of the M2 helices ; straight in the closed state
and kinked in the open state. These measurements may eventually be brought to the 4 A˚ reso-
lution of Unwin’s later cryo-electron studies (Unwin, 2005), but are currently insufficiently
resolved to identify the orientation of individual amino-acid side chains.
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7.2 Time-resolved mass spectrometry
As detailed in section 4, state-dependent cross-linking and SCAM experiments reveal that
residues change their distance from each other, or their water-accessibility, as the channel
opens, closes and desensitizes. A complementary technique uses photoaffinity labelling during
periods when the Cys-loop receptor is in the open, closed or desensitized state. Using
this technique, the membrane was kept intact to allow voltage control manipulations ; oocytes
expressing nAChR were exposed to constant ACh during a voltage-clamp experiment.
The receptors, which have voltage-dependent gating, were switched from open to closed by
voltage jumps. The oocyte was exposed to the lamp during 500 ms epochs that coincided
with either the open or closed states (Leite et al. 2003). Because of the photoprobe concentrates
in the membrane, mass spectrometry then revealed regions whose exposure to the membrane
changed during the state transitions. In the open state, there was specific probe incorporation
within the ECD in the b8–b9 loop. In the closed state, probe incorporation occurred within the
Cys-loop, and these findings agree well with present concepts about the gating interface. In the
closed state, there was also probe incorporation in the M3–M4 region, emphasizing that this
region too may move relative to the membrane during gating (Akk & Steinbach, 2000 ; Bouzat
et al. 1994).
7.3 Light-flash relaxations
Other strategies produce a perturbation at a structurally defined location, and then ask how the
receptor relaxes with a new equilibrium. The kinetics of the relaxation then reveal the speed of
a conformational change that propagates from the perturbed residue to the channel gate(s).
Unfortunately, the location of voltage dependence is unknown in those Cys-loop receptors (such
as the muscle nAChR) that display voltage-dependent kinetics. However, light-flash relaxations
are more informative, because they originate at known locations. In one example, the photo-
isomerizable nicotinic agonist Bis-Q was photoisomerized from the active, trans configuration to
the non-agonist cis configuration while the Bis-Q molecule was bound to the binding site.
Channels closed completely within <100 ms showing that dissociation of the agonist and
channel closure are linked to this time scale (Nass et al. 1978 ; Sheridan & Lester, 1982). The
photon cross-section for this closure corresponds to two Bis-Q molecules per channel, showing
that this conclusion applies to either of the two bound agonists. Information of this sort can be
obtained only indirectly from other kinetic studies.
In another example, the unnatural side chain Tyr-ONB, or caged Tyr, was introduced in place
of the Tyr residues in the nAChR a subunit at loop A (Tyr93), near the Cys-loop (Tyr127) or in
loop C (Tyr198). The mutant receptor did not respond to ACh. Flash decaging, in the presence
of ACh, produced conductance increases that covered a wide range of time scales (1 ms to 10 s),
with at least two phases in each case (Miller et al. 1998). The faster phase (t1) was governed by
the time course of the flash (y1 ms) ; this is important, because it implies that changing any of
these side chains to the native Tyr activates the gate within y1 ms. The time constant of the
slower phase (t2) was considerably slower : t2 at Tyr127 (13 ms) was faster than for Tyr198
(41 ms) or for Tyr93 (820 ms). We now understand that Tyr127 is closer to the channel gate than
are the other two side chains, and we also know that Tyr198 is on a loop that moves when
agonist binds in AChBP (Zheng & Zagotta, 2003). On the other hand, in most models, Tyr93
does not participate directly in conformational changes that open the channel. Thus, a structural
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change in a side chain influences the conductance more rapidly when it directly participates in the
gating pathway.
7.4 Rate-equilibrium free energy relationships
Rate-equilibrium free energy relationships (REFERs) provide a more general way to specify the
order at which various residues participate in the conformational changes that open and close the
gate (Edelstein et al. 1996 ; Grosman et al. 2000b). In this analysis, one performs a kinetic ex-
periment that can distinguish the rate of channel opening from that of channel closing. This can
be accomplished with macroscopic measurements, but is most simply done by measuring single-
channel kinetics at agonist concentrations so high that they saturate the binding step. The kinetic
and equilibrium data are compared for a set of mutations at a residue under investigation. If the
data are well behaved, they yield a parameter 0<W<1, which indicates the proximity of the
transition state controlled by the residue of interest. Values of W near 0 and 1 indicate that a
transition state is nearest to the open or closed state, respectively. Strikingly, the initial investi-
gation showed that progression of W, from near 1 to near 0, approximated the physical position
of residues from extracellular (near the binding site) to intracellular (near the channel gate),
respectively (Chakrapani et al. 2003 ; Grosman et al. 2000b). These data led to the conclusion that
opening proceeds in a conformational wave, from the binding site to the channel gate. Evidently,
the W values imply both mechanistic order and temporal order.
More recent analyses have shown clusters ofW values for neighbouring residues, giving rise to
the idea that domains of the receptor move together and allowing the ordering of conformational
changes that involve various domains. Thus, a recent analysis concludes that the residues at the
top of a-M2 region move at about the same time as the binding site (Bafna et al. 2008). Later in
the conformational wave, the M2 regions have several distinct steps at W values between 064
and 031 (Purohit et al. 2007).
7.5 Voltage-clamp fluorometry
Voltage-clamp fluorometry provides another way to identify changes in the local structure.
Fluorescence changes (DF) that differ from conductance changes are the more interest-
ing, whether these differences occur along the axis of time, agonist concentration, blocker
concentration or agonist efficacy. In the usual experiment, an introduced Cys residue is deriva-
tized with a Cys-reactive fluorophore whose fluorescence is highly dependent on local polarity.
The typical probe, tetramethylrhodamine, increases its fluorescence by factors approaching 100
when its environment becomes less polar. We do not yet fully understand the photophysical
nature of the relation between conformational changes and fluorescence, but can simply say that
a DF means a local change in the environment. Indeed, several Cys-loop experiments show that
the sign (positive or negative) of DF varies with position for closely spaced residues (Muroi et al.
2006 ; Dibas et al., HAL lab). We call this the ‘sign caution ’. One must also rule out a direct
interaction between the tethered fluorophore and the ligand under test, as well as making sure
that the ligand does not have a fluorescent signature of its own.
Following the lead of experiments on voltage-gated channels and neurotransmitter transpor-
ters, voltage-clamp fluorometry measurements usually involve a voltage-clamped oocyte, because
the large measureable membrane area provides better signal to noise ratios than experiments on
an individual voltage-clamped mammalian cell. The excised inside-out patch procedure, which
has proven to be useful for cyclic nucleotide-gated channels (Zheng and Zagotta, 2003), is less
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useful for channels gated by extracellular ligands and therefore has not been employed. There are
also indications that covalently bound fluorophores can sense structural changes in the GABAAR
that presumably originate at binding interfaces, and then propagate to a non-binding subunit that
has the fluorescent label (Muroi et al. 2006).
Concentration–response relationships are possible when the maximal DF/F (e.g. signal/
background) exceeds y2%. The data for GABAA and GABAC receptors show that fluoro-
phores tethered to loops A, C and E undergo agonist-induced conformational changes that
change the fluorescence of bound fluorophores ; these fluorescence changes have the same
concentration–response relationship as the conductance (Chang & Weiss, 2002). Thus, we have
another indication that part of the ECD moves as the channel opens ; but the small DF/F
prevented experiments that would compare the kinetics of the fluorescence changes and con-
ductance changes. Interestingly, fluorophores in loops A (Chang &Weiss, 2002) and E (Chang &
Weiss, 2002 ; Muroi et al. 2006) experience antagonist-induced fluorescence decrease, opposite to
the agonist-induced changes. This difference eliminates concerns about the ‘sign caution’. On
the other hand, a fluorophore in loop C exhibits similar changes whether the binding site is
occupied by agonists or antagonists (Chang & Weiss, 2002). These findings about antagonists
could not have been obtained from mutagenesis alone. Because of the ‘sign caution ’, the results
do not conflict with recent conclusions, mostly based on AChBP, that agonists allow loop C to
collapse on the agonist, while antagonists tend to push loop C away from the other loops (Gao
et al. 2006; Hansen et al. 2005). Picrotoxin, a pore blocker, does not induce DF by itself (Muroi
et al. 2006), but partially blocked DF for a loop E position, fully blocked DF for a loop A
position, and failed to block DF for a loop C position (Chang & Weiss, 2002). Pore block is a
complex kinetic and equilibrium phenomenon and detailed concentration–response experiments
for both agonist and blocker would be required to resolve the question of whether a fluorophore
in the ECD senses a different environment when the channel is blocked by picrotoxin (Lester,
1992).
The largest DF/F (10–20%) has been measured for the environment-sensitive fluorophore,
tetramethylrhodamine (TMR) tethered at the extracellular end (typically close to the channel
lining residue 19k) of the M2 region at the muscle nAChR (Dahan et al. 2004) or GlyR (Pless et al.
2007). These signals enable spectrally resolved studies on the fluorescence, verifying the expec-
tation (from studies in solution) that the emission spectrum shifts towards the blue as the
emission increases. The original report concerned the muscle nAChR b-subunit containing
TMR tethered to the 19kCys mutation ; but signals almost as large have now also been found
for the c19k and d19k positions as well (Dibas et al., unpublished results). The concentration–
response relations for agonist-induced DF are shifted well to the left of those for agonist-induced
current, implying that conformational changes occur at concentrations too low to open the
channel. Further experiments led to the conclusion that b19k positions events that closely follow
agonist binding at the ad interface. In this case, DF/F was sufficiently large to allow kinetic
studies, down to a time resolution of y5 ms. The kinetic studies showed that one or more
desensitized states of the nAChR retain the fluorescence increase, consistent with the idea that
most desensitized receptors have agonist bound. The question arose, does DF arise solely from
one or more desensitized states? The answer is no, because when the receptors were activated by
a flash-induced increase of the agonist trans-Bis-Q, DF was complete with 20 ms, one to two
orders of magnitude faster than desensitization (Dahan et al. 2004).
Experiments with tetramethylrhodamine tethered to a GlyR 19k Cys residue show that
large DF/F has the same Gly concentration–response relation as the Gly-induced conductance
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(Pless et al. 2007). But b-alanine and taurine produced robust DF without appreciably activation.
Propafol converted taurine and b-alanine to full agonists, yet failed to produce a Gly-like blue-
shifted emission spectrum. Thus, as in the nAChR, TMR at 19k reports a conformational change
associated with a binding event in the ECD that occurs in the absence of channel opening. On
the other hand, ivermectin, suspected of acting in the TMD, activates the channel without
inducing DF. Strychine, which competes at the binding site, blocks DF ; picrotoxin, which blocks
the channel, does not reduce DF.
Voltage-clamp fluorometry has justified its promise as a procedure that can reveal con-
formational changes induced by ligands, separable from those associated with channel opening
(Pless & Lynch, 2008). Cys-loop receptors apparently have wondrously complex conformational
states and flexibility. Unfortunately, voltage-clamp fluorometry has told us little about the specific
nature of the additional conformations.
7.6 Total internal reflection fluorescence
Some of Axelrod’s pioneering experiments with total internal reflection microscopy (TIRF) were
performed on muscle nAChRs labelled with antibodies (Wang & Axelrod, 1994). Since then,
many investigators have appreciated that TIRF is an optimal technique for resolving membrane-
associate proteins. Recent TIRF experiments with single-molecule resolution have utilized
channels that incorporate fluorescent proteins to count subunits in various ion channels (Ulbrich
& Isacoff, 2007). In a further refinement of the channel- and subunit-counting theme, it is now
possible to label nAChRs with fluorescent unnatural amino acids, which vastly decreases the
possible structural perturbation produced by the fluorophore (Pantoja et al. 2009). It is also
possible to count individual subunits with fluorescent ligands, either a-BTX (Pantoja et al. 2009)
or a Cy3-derivative of carbamoylcholine (Fujimoto et al. 2008). Within a given individual cell,
there is good agreement among the estimates for the number of channels from electro-
physiology, fused fluorescent proteins, the fluorescent unnatural side chain and fluorescent
a-BTX (Pantoja et al. 2009). It may also be possible to develop high-throughput assays for
5-HT3Rs with TIRF detection of fluorescent ligands (Hovius et al. 1999).
The ‘optical patch clamp’ is an entirely different use of single-molecule TIRF microscopy
(Demuro & Parker, 2005). Cells are injected with a dye whose fluorescence increases when it
binds Ca2+. When an nAChR channel opens, the resulting transient cytoplasmic microdomain of
increased fluorescence is sufficiently close to the membrane to be visualized by TIRF. The
increased fluorescence has a square-wave time course (at a temporal resolution of y2 ms) and
exhibits all the expected kinetics, pharmacology, dose-dependence and voltage dependence ex-
pected from single nAChR channels. The technique simultaneously images and resolves the
opening of hundreds of channels. It is especially encouraging that muscle nAChRs and normal
Ringer solutions were used in the experiment, because the muscle nAChR has a relatively lower
Ca2+ permeability than most nACh and 5-HT3Rs, implying that nearly all receptors could be
studied with the ‘optical patch clamp’.
8. Conclusions
Members of the Cys-loop of LGICs display considerable structural and functional homology. In
this review, we have seen how evidence from structural studies can often be applied across the
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whole family of receptors. Functional conservation cannot be better demonstrated than by the
creation of chimaeric receptors that combine varying regions of the different family members to
create new receptors that possess the functional properties of both receptors (i.e. Eisele´ et al.
1993 ; Galzi et al. 1996 ; Grutter et al. 2005a, b). Considering the level of sequence and structural
similarity between members, it is not surprising that there is also cross-talk by agonists (e.g.
Nakazawa et al. 1995; Macor et al. 2001) and antagonists within the group (e.g. Ballesetro et al.
2005 ; Broad et al. 2002; Drisdel et al. 2008; Gurley & Lanthorn, 1998; Macor et al. 2001 ;
Thompson & Lummis, 2008b). There has already been considerable research on these receptors,
and the more recent identification of new members (e.g. Histamine-gated (Beg & Jorgensen,
2003 ; Bocquet et al. 2007; Davies et al. 2002 ; Zheng et al. 2002), EXP-1 (Beg & Jorgensen, 2003),
Zinc-activated (Davies et al. 2002), ELIC (Hilf & Dutzler, 2008), proton-gated (Bocquet et al.
2007), glutamate-gated (Cully et al. 1994), MOD-1 (Ranganathan et al. 2000) and SsCl (Mounsey
et al. 2007)) suggests that others still remain undiscovered. A combination of traditional experi-
mental methods and some of the more recent developments described in section 7 will provide
us with further insights, many of which will be widely applicable to the whole Cys-loop receptor
family.
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